← FDA DRUG APPROVALS

FDA ANDA · ANDA214384

DROXIDOPA

Sponsor: SUN PHARM

APPLICATION
ANDA214384
TYPE
ANDA
ORIGINAL APPROVAL
2021-02-18
LATEST ACTION
2021-02-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DROXIDOPAPrescription
DROXIDOPA 300MG · CAPSULE · ORAL
DROXIDOPAPrescription
DROXIDOPA 100MG · CAPSULE · ORAL
DROXIDOPAPrescription
DROXIDOPA 200MG · CAPSULE · ORAL

Approval history

2021-02-18UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →